Profiling of autoantibodies in the sera of glioblastoma patients.

IF 2.7 4区 医学 Q3 IMMUNOLOGY
Johannes Low Jun Wei,Ammar Akram Kamarudin,Soon Bee Hong,Kamalanathan Palaniandy,Azizi Abu Bakar,Jegan Thanabalan,Ramesh Kumar Athi Kumar,Ainul Syahrilfazli Jaafar,Sanmugarajah Paramasvaran,Farizal Fadzil,Nadiah Abu
{"title":"Profiling of autoantibodies in the sera of glioblastoma patients.","authors":"Johannes Low Jun Wei,Ammar Akram Kamarudin,Soon Bee Hong,Kamalanathan Palaniandy,Azizi Abu Bakar,Jegan Thanabalan,Ramesh Kumar Athi Kumar,Ainul Syahrilfazli Jaafar,Sanmugarajah Paramasvaran,Farizal Fadzil,Nadiah Abu","doi":"10.1080/1750743x.2024.2390350","DOIUrl":null,"url":null,"abstract":"Aim: This study aimed to determine the expression pattern of autoantibody proteins from the serum of grade IV glioblastoma patients.Materials & methods: We performed high throughput antibody profiling via the Sengenics i-Ome® Protein Array to determine the differentially expressed autoantibodies.Results: The results portrayed that anti-COL4A3BP and anti-HSP90AA1 were among the upregulated autoantibodies in glioblastoma sera.Conclusion: The selected autoantibodies offer promising targets for future glioblastoma pathogenesis. However, further validation is required to elucidate the autoantibody signature in glioblastoma patients.","PeriodicalId":13328,"journal":{"name":"Immunotherapy","volume":"42 1","pages":"1-8"},"PeriodicalIF":2.7000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/1750743x.2024.2390350","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: This study aimed to determine the expression pattern of autoantibody proteins from the serum of grade IV glioblastoma patients.Materials & methods: We performed high throughput antibody profiling via the Sengenics i-Ome® Protein Array to determine the differentially expressed autoantibodies.Results: The results portrayed that anti-COL4A3BP and anti-HSP90AA1 were among the upregulated autoantibodies in glioblastoma sera.Conclusion: The selected autoantibodies offer promising targets for future glioblastoma pathogenesis. However, further validation is required to elucidate the autoantibody signature in glioblastoma patients.
分析胶质母细胞瘤患者血清中的自身抗体。
目的:本研究旨在确定IV级胶质母细胞瘤患者血清中自身抗体蛋白的表达模式:我们通过Sengenics i-Ome®蛋白质阵列进行了高通量抗体分析,以确定差异表达的自身抗体:结果:抗COL4A3BP和抗HSP90AA1是胶质母细胞瘤血清中上调的自身抗体之一:结论:所选自身抗体为未来胶质母细胞瘤的发病机制提供了有希望的靶点。结论:所选的自身抗体为未来胶质母细胞瘤的发病机制提供了有希望的靶点,然而,要阐明胶质母细胞瘤患者的自身抗体特征还需要进一步的验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Immunotherapy
Immunotherapy 医学-免疫学
CiteScore
5.00
自引率
3.60%
发文量
113
审稿时长
6-12 weeks
期刊介绍: Many aspects of the immune system and mechanisms of immunomodulatory therapies remain to be elucidated in order to exploit fully the emerging opportunities. Those involved in the research and clinical applications of immunotherapy are challenged by the huge and intricate volumes of knowledge arising from this fast-evolving field. The journal Immunotherapy offers the scientific community an interdisciplinary forum, providing them with information on the most recent advances of various aspects of immunotherapies, in a concise format to aid navigation of this complex field. Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal''s Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信